Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy

ABSTRACT Prevention of congenital rubella is achieved by vaccination of susceptible women of childbearing age. In Italy, the National Plan for Measles and Congenital Rubella Elimination 2010–2015 implemented catch-up vaccination activities targeting susceptible adolescents and young adults, including women of childbearing age. The aim of this study was to assess the immunity against rubella in women of childbearing age in Tuscany (Central Italy) and Apulia (Southern Italy) and pregnant women in Apulia after the implementation of the National Plan for Measles and Congenital Rubella Elimination. Overall, anti-rubella IgG prevalence in women of childbearing age samples was 88.6% in Tuscany and 84.3% in Apulia. The lowest prevalence was observed in samples of 26–35 years old women of childbearing age in Apulia with 77.8%. Only 62.7% of samples from 26–35 years old pregnant women had IgG against rubella, and one sample out of 95 was positive to IgM. The findings of this study highlight the need for increasing awareness on the risk of contracting rubella infection during pregnancy and implement vaccination strategies to create opportunities for administration of rubella containing vaccines in young girls and women of childbearing age.

[1]  E. Montomoli,et al.  Low prevalence of antibodies against pertussis in pregnant women in Italy. , 2019, Lancet. Infectious Diseases (Print).

[2]  E. Montomoli,et al.  Measles in pregnancy: a threat for Italian women? , 2019, Human vaccines & immunotherapeutics.

[3]  S. Tafuri,et al.  Erratum to: lack of immunity against rubella among Italian young adults , 2017, BMC Infectious Diseases.

[4]  M. C. Rota,et al.  Underreporting of congenital rubella in Italy, 2010–2014 , 2017, European Journal of Pediatrics.

[5]  G. Filomena,et al.  Lack of immunity against rubella among Italian young adults , 2017, BMC Infectious Diseases.

[6]  S. Declich,et al.  Congenital rubella still a public health problem in Italy: analysis of national surveillance data from 2005 to 2013. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[7]  M. Levi,et al.  Progress in the elimination of measles and congenital rubella in Central Italy , 2013, Human vaccines & immunotherapeutics.

[8]  M. L. Ciofi Degli Atti,et al.  Rubella seroprofile of the Italian population: an 8-year comparison , 2006, Epidemiology and Infection.

[9]  A Pedicini,et al.  Piano Nazionale per l’Eliminazione del Morbillo e della Rosolia Congenita (Pnemorc) 2010-15: Stato di Avanzamento delle Coperture Vaccinali in Abruzzo , 2014 .

[10]  Rubella vaccines: WHO position paper. , 2011, Releve epidemiologique hebdomadaire.

[11]  S. Salmaso,et al.  Immunization coverage in Italy. , 1987, Bulletin of the World Health Organization.